Business UpdateThe Daily Yomiuri, Japan - Aug 27, 2007Teijin Pharma Ltd., the drugs unit of the nation's second-biggest textile maker, is developing a diabetes medicine with Chugai Pharmaceutical Co. and …
Read full story
Teijin and Chugai Enter an Agreement to Co-develop Ipsen's Anti …PharmaLive.com (press release), PA - Aug 23, 2007TOKYO, August 23, 2007 - Teijin Pharma Limited ("Teijin"; headquarters: Chiyoda-ku, Tokyo; President: Shigeo Ohyagi) and Chugai Pharmaceutical Co., …
Read full story
Aspreva and Roche Update CellCept AgreementPharmaLive.com (press release), PA - Aug 29, 2007Aspreva is a global pharmaceutical company focused on identifying, developing, and, upon approval, commercializing evidence-based medicines for patients …
Read full story
Chugai Recalls Batch of Vesanoid in JapanFDA news (subscription), VA - Aug 6, 2007Japanese drug company Chugai Pharmaceutical announced that it is voluntarily recalling Vesanoid capsules, a treatment for acute promyelocytic leukemia, …
Read full story
Vesanoid with bovine-derived material recalled in JapanIn-PharmaTechnologist.com, UK - Aug 6, 2007By Katrina Megget 06/08/2007 - Japan's Chugai Pharmaceuticals is voluntarily recalling almost 2000 bottles of Vesanoid capsules (tretinoin) after the drug …
Read full story
Roche and Actavis agree on product transactionsPipelineReview.com (press release), Spain - Aug 13, 2007BASEL, Switzerland | August 13, 2007 | Roche and Actavis, a leading generic pharmaceutical company based in Iceland, have signed agreements for the sale of …
Read full story
Report Highlights Impact of Recent Entries and New Mechanisms on …PharmaLive.com (press release), PA - Aug 16, 2007SCOTTSDALE, Ariz., August 16, 2007 /PRNewswire/ — MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market …Chugai Pharmaceutical Co - Google News
Read full story
Report Highlights Impact of Recent Entries and New Mechanisms on …PR Newswire (press release), NY - 1 hour ago16 /PRNewswire/ — MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report …
Read full story
Chugai Pharmaceutical: To Recall Leukemia Drug In JapanTherapeutics Daily (subscription) (press release), PA - Aug 3, 2007TOKYO -(Dow Jones)- Chugai Pharmaceutical Co. (4519.TO) said Friday it has started recalling a leukemia drug, Vesanoid, in Japan as a specified batch of the …
Read full story
Japan's Stocks Advance, Led by Mitsubishi Estate on Land PricesBloomberg - Aug 1, 2007Chugai Pharmaceutical Co. climbed 60 yen, or 3 percent, to 2080. The Japanese unit of Roche Holding AG increased its full- year profit estimate by 8.1 …
Read full story
Roche's Chugai recalls Vesanoid capsules against leukemai …Forbes, NY - 21 hours agoTOKYO (Thomson Financial) - Roche Holding AG unit Chugai Pharmaceutical Co Ltd announced it is voluntarily recalling Vesanoid capsules used as a treatment …Chugai Pharmaceutical: To Recall Leukemia Drug In Japan Therapeutics Daily (subscription) (press release)A Voluntary Recall of a Specific Batch of “Vesanoid Capsule,” a … PharmaLive.com (press release)all 8 news articles
Read full story
Japan Outlook: Hitachi, Mazda, NEC, Tepco 1Q; June JoblessFXstreet.com The Foreign Exchange Market, Spain - Jul 30, 2007CORPORATE EVENTS 0600 Chugai Pharmaceutical Co. (4519.TO) reports earnings for the fiscal first half. 0200 - Teijin Ltd. (3401.TO) - Fuji Heavy Industries …
Read full story
Equities NewsLand prices figures help Tokyo to gainsEquities News, UK - 23 hours agoDrug maker Chugai Pharmaceutical (TYO: 4519) gained 2.7 percent to ¥2075 on an increased full-year projecting, while Astellas Pharma (TYO: 4503) was 3.1 …
Read full story
A Voluntary Recall of a Specific Batch of “Vesanoid Capsule,” a …PharmaLive.com (press release), PA - 3 hours agoTOKYO, August 3, 2007 - Chugai Pharmaceutical Co., Ltd (Head office: Chuo-ku, Tokyo; President: Osamu Nagayama, hereafter, “Chugai”) announced today that it …Chugai Pharmaceutical: To Recall Leukemia Drug In Japan Therapeutics Daily (subscription) (press release)Roche's Chugai recalls Vesanoid capsules against leukemai … CNNMoney.comRoche's Chugai recalls Vesanoid capsules against leukemai … ABCmoney.co.ukall 6 news articles
Read full story
Top Products Help ProfitWall Street Journal - Jul 31, 2007Chugai Pharmaceutical Co., which reported first-half results, said group net profit grew 12% to 21.11 billion yen from 18.79 billion yen from the same …
Read full story
Philadelphia InquirerJapanese Stocks Rise as Cheap Shares Attract Buyers; Banks DropBloomberg - 9 hours agoChugai Pharmaceutical Co. climbed 55 yen, or 2.7 percent, to 2075. The Japanese unit of Roche Holding AG increased its full- year profit estimate by 8.1 …Japan's Stocks Advance, Led by Mitsubishi Estate on Land Prices Bloombergall 82 news articles
Read full story
Sanofi-aventis First Half 2007: Solid Results in a Difficult Context;CNNMoney.com - Aug 1, 2007These products are currently marketed by Chugai and Mitsubishi. The adjusted consolidated income statement is presented in Appendix 3. …
Read full story
Termination of Product Marketing Collaboration Between Sanofi …PharmaLive.com (press release), PA - 1 hour agoNet sales for the 7 products totaled 12926 million yen in Chugai Pharmaceutical fiscal year 2006. Sanofi-aventis is one of the world's leading …
Read full story
Japan family to sue government over TamifluChina Post, Taiwan - Jul 24, 2007Tamiflu is widely prescribed in Japan, with Chugai Pharmaceutical Co. Ltd., the Japanese importer and distributor of Tamiflu, estimating some 35 million …
Read full story
UPDATE: Roche's Actemra Better Than Standard RA TreatmentCNNMoney.com - Jul 25, 2007Actemra, also known as tocilizumab, was developed by Japanese pharmaceutical company Chugai Pharmaceutical Co. (4519.TO), which is controlled by Roche. …
Read full story